Fig. 4From: Identification of novel drugs to target dormant micrometastasesCell cycle analysis of DT310 and DT320 treatment of MDA-MB-435 cells. Cells were treated 24 h with 100 μM followed by Propidium iodide staining and flow cytometry. Data are means +/−SEM of triplicate samples. * = P <0.05, ** = P <0.01, **** = P <0.001 by one-way ANOVA with Dunnett’s post-testBack to article page